Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:EXAM

(EXAM) (EXAM) Stock Price, News & Analysis

(EXAM) logo

About (EXAM) Stock (NYSE:EXAM)

Advanced Chart

Key Stats

Today's Range
$35.05
$35.17
50-Day Range
N/A
52-Week Range
$21.98
$37.26
Volume
3.56 million shs
Average Volume
660,679 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.

Receive EXAM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter.

EXAM Stock News Headlines

Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
See More Headlines

EXAM Stock Analysis - Frequently Asked Questions

(EXAM) (NYSE:EXAM) issued its quarterly earnings data on Tuesday, May, 10th. The business services provider reported $0.08 EPS for the quarter, hitting the consensus estimate of $0.08. The business's revenue was up 15.4% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (EXAM) investors own include Bristol-Myers Squibb (BMY), Ciena (CIEN), Best Buy (BBY), China Biologic Products (CBPO), Community Health Systems (CYH), Diplomat Pharmacy (DPLO) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/10/2016
Today
4/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Services
Current Symbol
NYSE:EXAM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:EXAM) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners